Remote Ischaemic Preconditioning in Transplantation (RIPTRANS)

Status Recruiting

Clinical Trial Summary

Remote ischemic preconditioning (RIPC) is a concept where remotely induced ischemia produces protection against ischemia-reperfusion injury in a remote organ. RIPC has been studied extensively in animal models and heart surgery, but it's benefit in transplantation has been studied less. The primary aim of this study is to find out whether RIPC performed in a donor in donation after brain-death (DBD) could improve delayed graft function rate of kidney transplants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Transplant Dysfunction

Clinical Trial Details

NCT number	NCT03855722
Study type	Interventional
Source	Helsinki University Central Hospital
Contact	Ville Sallinen, MD, PhD
Phone	+358-9-4711
Email	ville.sallinen@helsinki.fi
Status	Recruiting
Phase	N/A
Start date	March 12, 2019
Completion date	February 2042

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06025240` - Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Completed	`NCT03446196` - Hemodynamic Optimization During Single Kidney Transplantation With MostcareUP	N/A
Completed	`NCT04019353` - Cf-DNA Assay During Treatment of Acute Rejection
Withdrawn	`NCT03314376` - Prehabilitation in Patients on a Waiting List for a Transplant	N/A
Completed	`NCT04643665` - Prediction of Pulmonary Graft Dysfunction After Double-lung Transplantation (PGD3-AI Study)
Recruiting	`NCT03602807` - Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients.	N/A
Not yet recruiting	`NCT05951231` - Liver Transplantation After ex Vivo Liver Perfusion	N/A
Completed	`NCT03123796` - Effects of Proton Pump Inhibitors on Kidney Transplant Recipients	N/A